abstract |
Described herein is a method of treating an influenza virus infection, wherein an effective amount of a MASP1 (mannan-binding lectin serine protease 1) inhibitor or a PRSS33 (protease, serine, 33) inhibitor is administered to an individual in need of such treatment. |